| From visual exploration to storytelling and back again S Gratzl, A Lex, N Gehlenborg, N Cosgrove, M Streit Computer Graphics Forum 35 (3), 491-500, 2016 | 110 | 2016 |
| Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets D Varešlija, N Priedigkeit, A Fagan, S Purcell, N Cosgrove, PJ O’Halloran, ... JNCI: Journal of the National Cancer Institute 111 (4), 388-398, 2019 | 94 | 2019 |
| The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export J Vohhodina, EM Barros, AL Savage, FG Liberante, L Manti, P Bankhead, ... Nucleic acids research 45 (22), 12816-12833, 2017 | 93 | 2017 |
| Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities N Cosgrove, D Varešlija, S Keelan, A Elangovan, JM Atkinson, ... Nature communications 13 (1), 514, 2022 | 48 | 2022 |
| Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer AL Browne, S Charmsaz, D Varešlija, A Fagan, N Cosgrove, S Cocchiglia, ... Oncogene 37 (15), 2008-2021, 2018 | 33 | 2018 |
| Epigenome-wide SRC-1–mediated gene silencing represses cellular differentiation in advanced breast Cancer E Ward, D Varešlija, S Charmsaz, A Fagan, AL Browne, N Cosgrove, ... Clinical Cancer Research 24 (15), 3692-3703, 2018 | 19 | 2018 |
| A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis L Zhu, D Retana, P García‐Gómez, L Álvaro‐Espinosa, N Priego, ... EMBO Molecular Medicine 14 (3), e14552, 2022 | 12 | 2022 |
| Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic … D Varešlija, E Ward, SP Purcell, NS Cosgrove, S Cocchiglia, ... Oncogene 40 (7), 1318-1331, 2021 | 11 | 2021 |
| ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis S Charmsaz, B Doherty, S Cocchiglia, D Varešlija, A Marino, N Cosgrove, ... BMC medicine 18, 1-14, 2020 | 7 | 2020 |
| An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer P Borde, N Cosgrove, S Charmsaz, ST Safrany, L Young Cancer gene therapy 30 (2), 368-374, 2023 | 3 | 2023 |
| Abstract PD13-01: Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases NS Cosgrove, D Varešlija, S Keelan, S Furney, JM Carter, SN Hart, ... Cancer Research 81 (4_Supplement), PD13-01-PD13-01, 2021 | | 2021 |
| SRC1-driven network of transcription factors mediates hormone treatment resistance D Vareslija, A Browne, A Fagan, N Cosgrove, E Ward, L Young Cancer Research 77 (13_Supplement), 5631-5631, 2017 | | 2017 |
